What to expect in the iRhythm Holdings, Inc. interview process

Based on publicly available sources, iRhythm Holdings, Inc. (NASDAQ: IRTC) is a San Francisco-founded digital healthcare and medical device company specializing in ambulatory cardiac monitoring, most notably through its Zio services. Founded in 2006 and publicly traded following its 2016 IPO, the company operates with a market cap of approximately $3.7B to $4.15B and reported annual revenues around $747.1M.

Data regarding the company's internal workplace realities—such as specific interview stages, management styles, return-to-office policies, or day-to-day employee workloads—are not detailed in the provided sources. However, workforce intelligence data indicates that iRhythm's global headcount has grown steadily, moving from roughly 1,793 employees in 2022 to approximately 2,441 employees worldwide by March 2026. The organization maintains a multi-country footprint spanning the United States, United Kingdom, Philippines, Netherlands, and Switzerland.

Hiring activity shows growth, with public records showing 133 active job postings in 2026—representing a 19.8% increase compared to 2025. Executive compensation figures place CEO Quentin S. Blackford's annual pay at approximately $2.08M, alongside executive leadership including CFO Daniel G. Wilson, Chief Medical & Scientific Officer Dr. Minang P. Turakhia, and Chief Business & Legal Officer Patrick Michael Murphy.